On Monday, in the course of current trade, Shares of Energy Transfer Equity LP (NYSE:ETE), climbed 3.07%, and is now trading at $28.26.
Energy Transfer Equity, stated financial results for the quarter ended June 30, 2015.
Distributable Cash Flow, as adjusted, for the three months ended June 30, 2015 was $335 million contrast to $218 million for the three months ended June 30, 2014, an enhance of $117 million. Distributable Cash Flow, as adjusted, per unit was $0.31 for the three months ended June 30, 2015, an enhance of 55% contrast to the three months ended June 30, 2014. ETE’s net income attributable to partners was $298 million for the three months ended June 30, 2015 contrast to $164 million for the three months ended June 30, 2014, an enhance of $134 million.
Energy Transfer Equity, L.P., through its auxiliaries, provides diversified energy-related services in the Unites States. It owns and operates about 7,700 miles of natural gas transportation pipelines and 3 natural gas storage facilities located in the state of Texas; and about 12,800 miles of interstate natural gas pipeline.
During an Afternoon trade, Shares of La Quinta Holdings Inc (NYSE:LQ), climbed 1.52%, and is now trading at $20.78.
La Quinta Holdings, stated its second quarter results on a historical basis, in addition to the results of operations on a pro forma basis, giving effect to La Quinta’s initial public offering (IPO) in 2014 and the related transactions as described below.
Second Quarter 2015 Highlights contrast to Second Quarter 2014:
- Pro Forma Total Adjusted EBITDA raised 5.5 percent to $111.8 million, and Pro forma Adjusted EBITDA margin raised 30 basis points
- Pro Forma Adjusted Net Income raised 17.8 percent to $24.2 million; historical net loss was $(4.7) million
- Pro Forma Adjusted Earnings per Share raised by $0.03 to $0.19; historical loss per share was $(0.04)
- System-wide comparable RevPAR raised 4.0 percent, ADR raised 3.0 percent and occupancy raised 67 basis points
- Pro Forma Franchise and Administration Segment Adjusted EBITDA raised 6.4 percent to $30.1 million
- Opened 15 franchised hotels totaling over 1,300 rooms and raised franchise pipeline to 219 hotels, which comprises about 18,600 additional rooms, counting the addition of two locations in Manhattan
- Pro Forma Owned Hotels Segment Adjusted EBITDA raised 7.9 percent to $90.6 million
- Board of Directors approved moving forward with a $200 million share repurchase program once net debt to Pro Forma Adjusted EBITDA ratio falls below 4.0
- Voluntarily prepaid additional $70 million of long-term debt
La Quinta Holdings Inc. owns, operates, and franchises select-service hotels under the La Quinta brand. It serves the upper-midscale and midscale segments. As of May 7, 2015, the company had about 870 hotels with about 86,000 rooms under the La Quinta Inn & Suites, La Quinta Inn, and LQ Hotel brands in 47 states of the United States, in addition to in Canada, Mexico, and Honduras.
Finally, Ligand Pharmaceuticals Inc. (NASDAQ:LGND), gained 1.59% Monday.
Ligand Pharmaceuticals Incorporated, stated financial results for the three and six months ended June 30, 2015, and offered an operating forecast and program updates.
Financial highlights for the second quarter of 2015 comprise:
- Total revenues were $18.4 million and royalty revenues were $6.6 million, an enhance of 74% and 26%, respectively, contrast with the second quarter of 2014.
- Adjusted EPS was $1.81 and GAAP EPS was $1.11.
- The company generated operating cash of $17.6 million, a noteworthy enhance over $6.6 million of operating cash generated in the second quarter of 2014.
Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs comprise Promacta, an oral medicine that enhances the number of platelets in the blood; Kyprolis that is used for the treatment of multiple myeloma; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; and Captisol-enabled Noxafil-IV, a formulation of posaconazole for intravenous (IV) use.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.